SCHEMBL18178307

SCHEMBL18178307

COC(=O)Oc1cccc(CO)c1COc1cc(Cl)c(C)cc1C(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 2/20 0.37
FABP5 Q01469 2/20 0.37
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GAA P10253 2/20 0.36
HTT P42858 2/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MRGPRX4 Q96LA9 5/20 0.35
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
AKR1C3 P42330 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178302 0.93 MRGPRX4 (0.38) FABP4FABP5LMNASMN1; SMN2ALDH1A1
SCHEMBL18178404 0.92 KDM4E (0.33) FABP4FABP5LMNANPSR1MAPT
SCHEMBL18178306 0.91 FABP4 (0.37) FABP4FABP5LMNASMN1; SMN2ALDH1A1
SCHEMBL18178668 0.90 MRGPRX4 (0.36) FABP4FABP5LMNASMN1; SMN2ALDH1A1
SCHEMBL18178303 0.90 LMNA (0.38) FABP4FABP5LMNASMN1; SMN2ALDH1A1
SCHEMBL18178305 0.90 LMNA (0.38) FABP4FABP5LMNASMN1; SMN2ALDH1A1
SCHEMBL18178208 0.89 GUCY1B2 (0.35) FABP4FABP5LMNAALDH1A1MAPT
SCHEMBL18178259 0.89 MRGPRX4 (0.40) FABP4FABP5LMNASMN1; SMN2ALDH1A1
SCHEMBL18178280 0.89 LMNA (0.38) FABP4FABP5LMNASMN1; SMN2ALDH1A1
SCHEMBL18178304 0.88 LMNA (0.39) FABP4FABP5LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 FABP4 4134/4885FABP5 3786/4885LMNA 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.